Michael F. Cannon Pharmaceutical giant Merck is suing Medicare, claiming new drug‐pricing reforms that Congress enacted in last year’s Inflation Reduction Act coerce the company into selling its wares to the program at below‐market prices. In the Wall Street Journal, attorney Daniel Troy opines that the